[ad_1]
Contents
Israeli scientists: “In a few weeks we will have a coronavirus vaccine”Once a vaccine is developed, it will take at least 90 days to complete the regulatory process, and it may take longer to enter the market.Israeli scientists are about to develop the first drug to treat this new coronavirusMinister of Science and Technology Ofir Akunis said. If all goes according to plan, a vaccine could be ready in a few weeks and available in 90 days, according to a press release. “Congratulations to MIGAL (Migal Institute of Galilee) for this exciting breakthrough,” Akunis said. “I am sure there will be further rapid advances that will allow us to mount the necessary response to the serious global threat of COVID-19,” Akunis said, referring to the disease caused by the novel coronavirus. For the past four years, a team of scientists at MIGAL has been developing a vaccine Targets the infectious bronchitis virus (IBV), which causes a bronchial disease that affects poultry. The vaccine’s effectiveness has been demonstrated in preclinical trials conducted at the Veterinary Institute. MIGAL is located in Galilee. “Our basic philosophy is to develop technologies, not vaccines specifically targeting this or that virus,” says Dr. Chen Katz, head of the biotechnology group at MIGAL. “The scientific framework of the vaccine is based on a new protein expression vector that forms and secretes a chimeric soluble protein that delivers viral antigens to mucosal tissues via self-activated endocytosis, which allows the body to form antibodies against the virus.”
Israeli scientists: “In a few weeks we will have a coronavirus vaccine”
Once a vaccine is developed, it will take at least 90 days to complete the regulatory process, and it may take longer to enter the market.
Israeli scientists are about to develop the first drug to treat this new coronavirusMinister of Science and Technology Ofir Akunis said. If all goes according to plan, a vaccine could be ready in a few weeks and available in 90 days, according to a press release. “Congratulations to MIGAL (Migal Institute of Galilee) for this exciting breakthrough,” Akunis said. “I am sure there will be further rapid advances that will allow us to mount the necessary response to the serious global threat of COVID-19,” Akunis said, referring to the disease caused by the novel coronavirus. For the past four years, a team of scientists at MIGAL has been developing a vaccine Targets the infectious bronchitis virus (IBV), which causes a bronchial disease that affects poultry. The vaccine’s effectiveness has been demonstrated in preclinical trials conducted at the Veterinary Institute. MIGAL is located in Galilee. “Our basic philosophy is to develop technologies, not vaccines specifically targeting this or that virus,” says Dr. Chen Katz, head of the biotechnology group at MIGAL. “The scientific framework of the vaccine is based on a new protein expression vector that forms and secretes a chimeric soluble protein that delivers viral antigens to mucosal tissues via self-activated endocytosis, which allows the body to form antibodies against the virus.”
MIGAL lab (Credit: Lior Journo) Endocytosis is a cellular process in which substances are brought into a cell by surrounding them with a cell membrane, forming a vesicle that contains the ingested material.
[ad_2]
Source link
